Investival Showcase - GMT (Greenwich Mean Time, GMTZ)
- Alexandra Zemp - Partner, McKinsey & Co.
- Joseph Lydon - Partner, McKinsey & Co.
- Maha Radhakrishnan - Executive Partner, Sofinnova Investments
- Tim Haines - Executive Partner, Abingworth
- Helena Fraser - VP, Life Sciences & Healthcare, HSBC Innovation Banking
- Regina Hodits - Managing Partner, Wellington Partners
- Gil Bar-Nahum - MD, Global Healthcare Investment Banking, Jefferies
Join Cooley’s US and UK capital markets partners for an overview of the Nasdaq listing process, including the following topics:
- Benefits and considerations for a US listing
- Benefits for Foreign Private Issuers
- Timeline and process overview
- Key workstreams, including drafting your SEC registration statement
- Financial statements
- Shareholder approvals and pre-IPO reorganisation
- Corporate governance and board appointments
- What you can do now, to prepare
- Katie Kazem - Partner, Cooley
- Claire Keast-Butler - Partner, Cooley
- Choosing the right deal structure that meets your commercial objectives
- The impact of challenging funding environment on deal terms
- Impact of market access consideration policy changes on deal-making,
- Impact of new technology on deal structures including AI
- Trends for commercialization structures
- Top tips for negotiation tactics
- Lillian Alcatraz - VP, Early Innovation Partnering, Johnson & Johnson Innovation EMEA
- Oren Livne - Partner, Global Life Sciences Transactions, Baker McKenzie
- Julie Yeni - Partner, Baker McKenzie
- Julia Schieber - Partner, Baker McKenzie
- Henrique Frizzo - Partner, Trench Rossi Watanabe
• Timelines
• Team
• Initial considerations
• Vendor due diligence
• Transaction Documents
• How to maximise value on exit
• W&I insurance
- Melanie Howard - Partner, Latham & Watkins
- Antonina Semyachkova - Associate, Latham & Watkins
Bring Your Brilliant Ideas to Life via a global life science incubator network
Are you a natural problem solver that has started to explore your revolutionary idea to change healthcare? Learn more about how Bayer Co.Lab can help you on your journey. Participants will engage in discussions about unique resources, mentorship opportunities, and global collaborative environments that Bayer Co.Lab incubators provide to foster innovation and accelerate startup growth. With our newest incubator in Berlin embedded in our global Pharmaceutical Headquarters opening soon, emerging companies will receive tailored support, access to industry expertise, and equipped facilities. Join us to learn more about how we can help you Bring Your Brilliant Ideas to Life!
- Ruth Shah - Head of Co.Lab Berlin, Bayer
- Pierre-Louis Joffrin - Associate Partner, Syncona
- Khatereh Ahmadi - Head of Search and Evaluation Team, European BD&L Hub, MSD
- Anne Horgan - Partner, CIC
- Ros Deegan - CEO, OMass Therapeutics
- Karin Kleinhans - Partner, MRL Ventures
- Giovanni Rizzo - Partner Biotech Fund, Indaco Venture Partners
- Cassie Doherty - Investment Director, Parkwalk Advisors
- Edward van Wezel - Managing Partner, BioGeneration Ventures
- Tom Goodman - Partner, Cooley
- Pascale Eede - Associate, Apollo Health Ventures
- Nate Chang - Operating Partner, Playground Capital
- Vanela Bushi - Co-founder & GP, H Tree Capital
- Daniela Begolo - Managing Director, EQT Life Sciences
- Gonzalo Garcia - Investment Partner, Syncona
- Arthur Franken - General Partner, Gilde Healthcare
- Ben Brickell - Partner, Stevenson Search
- Marta Helena Lesko - VP, Head of Neurology and Immunology Business Development, Merck Group
- Catherine Pickering - CEO & Founder, iOnctura
- Ivan Griffin - Chief Business Officer, Co-Founder, BenevolentAI
- Melanie Toyne-Sewell - Managing Director, Vigo Consulting
- John Rudy - Member / Co-chair, Securities & Capital Markets Practice, Mintz
- Roby Kanichay - Executive Director, Business Development, Merck Healthcare KGaA
- Mathias Vinther - Principal, Forbion
- Bettina Ernst - CEO, BERNINA BioInvest
- Edouard Guillet - Managing Partner, IPF Partners
- Herve de Kergrohen - Venture Partner, Alpha Blue Ocean
- John Cassidy - Investment Director, SoftBank
- Ajan Reginald - CEO, Roquefort Therapeutics Plc
- Herke van Hulst - Partner, Osborne Clarke
- Rabab Nasrallah - Principal, Earlybird Venture Capital
- Bettina Ernst - CEO, BERNINA BioInvest
- Nadiya Ishnazarova - Principal, M Ventures
- Amanda Gett - Partner, Kurma Partners
- Sara Secall - Partner, Inveready
- Bonnie van Wilgenburg - Principal, Monograph Capital
- Jody Thelander - Founder & CEO, J. Thelander Consulting